Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference77 articles.
1. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell cancer by the Lung Cancer Study Group;Ginsberg;Ann Thorac Surg,1995
2. Lung cancer in octogenarians: factors affecting long-term survival following resection;Dominguez-Ventura;Eur J Cardiothor Surg,2007
3. Lobectomy for treating bronchial carcinoma: Analysis of comorbidities and their impact on postoperative morbidity and mortality;Sanchez;J Bras Pneumol,2006
4. Lobectomy-video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial;Kirby;J Thoraco Cardiovasc Surg,1995
5. Video-assisted thorascocopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer;Sugi;World J Surg,2000
Cited by 68 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Adaptive hypofractionted and stereotactic body radiotherapy for lung tumors with real-time MRI guidance;Frontiers in Oncology;2023-01-27
2. The histologic effects of neoadjuvant stereotactic body radiation therapy (SBRT) followed by pulmonary metastasectomy—rationale and protocol design for the Post SBRT Pulmonary Metastasectomy (PSPM) trial;Translational Cancer Research;2022-04
3. Toxicity and efficacy of stereotactic body radiotherapy for ultra-central lung tumours: a single institution real life experience;The British Journal of Radiology;2022-01-01
4. Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non–small-cell Lung Cancer;Clinical Lung Cancer;2021-05
5. Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical study;Radiation Oncology;2021-01-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3